Engineered to meet rigorous mechanical standards, our primary trauma stabilization assemblies deliver optimized weight-to-rigidity ratios for swift clinical interventions in the US market.
The United States external fixation market operates under high regulatory pressure and clinical expectations. With Level I and II trauma centers handling over 40 million visits annually, the demand for dynamic, robust, and intuitive stabilization systems is at an all-time high. Surgeons demand lightweight, radiolucent materials that minimize imaging artifacts, while hospitals face persistent pressure to contain costs without compromising patient outcomes.
This dual mandate of clinical excellence and cost-efficiency has altered the relationship between medical device providers and global manufacturing plants. To remain competitive, US distributors and OEM brands are increasingly transitioning from local manufacturing to trusted global partnerships. This shift requires factories that possess cleanrooms, CNC Swiss machining lines, and a deep understanding of FDA 510(k) clearances and ASTM F1541 mechanical testing guidelines.
Modern external skeletal fixators must bridge the gap between temporary structural splinting and long-term bone healing. Advanced constructs utilize Ti-6Al-4V ELI (Grade 23) and carbon fiber composites to provide stability, promote controlled micro-motion for osteogenesis, and lower the risk of stress shielding.
Additionally, specialized coatings like anodization and electropolishing are essential for mitigating pin-track infections. By ensuring low surface roughness and precise tolerances down to ±0.005mm, high-end fabrication houses protect both the integrity of the device and the physiological recovery of the patient.
Synoviq Medical Technology (China) Co., Ltd. is a professional manufacturer of orthopedic implants and surgical instruments, dedicated to delivering innovative, reliable, and high-quality medical solutions for healthcare professionals worldwide. Since its establishment, Synoviq has focused on research, development, precision manufacturing, and international quality standards, providing comprehensive OEM and ODM services for global medical device brands, distributors, and hospitals.
Our product portfolio includes trauma fixation systems, spinal implants, locking plates, intramedullary nails, external fixation systems, orthopedic screws, surgical instruments, and customized orthopedic solutions. Equipped with advanced CNC machining centers, precision inspection equipment, and modern clean production facilities, we ensure every product meets strict international quality requirements.
Driven by continuous innovation, Synoviq invests heavily in R&D and intelligent manufacturing to enhance product performance, surgical efficiency, and patient outcomes. Our experienced engineering team works closely with customers to develop customized products tailored to different clinical applications and market demands.
With a customer-oriented philosophy, competitive pricing, stable supply capability, and efficient technical support, Synoviq has established long-term partnerships with distributors, medical brands, and healthcare organizations across Europe, North America, South America, the Middle East, and Asia-Pacific.
| Specification Category | Technical Capability & Operational Metrics |
|---|---|
| Company Name & Brand | Synoviq Medical Technology (China) Co., Ltd. (Synoviq) |
| Establishment & Experience | Established March 18, 2016; 14 years industry experience; 8 years export history. |
| Building Area | 18,600 m² state-of-the-art facility featuring ISO Class 7/Class 10,000 cleanrooms. |
| Annual Export Revenue | USD 21.8 Million, supporting markets across North America, Europe, and Asia. |
| Quality Inspection & Testing Staff | 48 Quality Control specialists performing 100% Final and Incoming Material Inspections. |
| Product Validation Methods | CMM Measurement, Mechanical Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Testing, Sterility Validation. |
| R&D Capabilities | 76 R&D Engineers; 186 new products released last year. Independent product design & rapid prototyping. |
| Supply Chain & Customization | 1,120+ active partners. Custom options include packaging, surface treatment, materials, and custom toolsets. |
From raw bar stock selection to automated optical inspection, our production line implements rigorous control loops to guarantee device safety.
External skeletal fixation remains a critical tool for managing complex periarticular fractures, open comminuted fractures, and limb length discrepancies. However, these systems present clear engineering challenges: pin-to-clamp slippage, mechanical fatigue under cyclical gait loads, and radiopacity impeding post-operative radiological evaluations.
To verify safety for the US market, every external fixator assembly undergoes strenuous testing. This includes:
We use nitric and citric acid passivation protocols (conforming to ASTM A967) to eliminate free iron molecules from the surface of stainless steel components (316LVM). This process builds a dense chromium oxide passive layer that resists physiological corrosion, preventing metal ion release and reducing the risk of adjacent soft tissue inflammation.
The future of trauma fixation centers on digitization and smart implants. Synoviq is currently investing in and developing several next-generation platforms to meet upcoming clinical demands:
Critical answers for orthopedic procurement officers, design engineers, and regulatory managers.
Browse our full range of modular components, dynamic joint connectors, and specialized surgical instruments engineered for clinical applications in the United States.
Synoviq Medical